Skip to main content scroll back to top of page

Utility Navigation

Careers

Primary Navigation

Close Menu

Pipeline
- Our Pipeline
  Our PipelineOur Pipeline
  Imipridones Tembexa®
  Oncology
  
  ONC201 for gliomas
  
  ONC206 for central nervous system tumors
  
  ONC212 IND-enabling studies
  
  Biodefense
  
  TEMBEXA^® for smallpox
  
  Publications Presentations SNO Conference
Company
Patients
- Expanded Access
- Clinical Trials
Products
- TEMBEXA®
Investors
Contact

« All Publications

bcv

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity

Antiviral Res. 2009

View Publication

Chimerix on LinkedIn
Chimerix on Twitter

Legal Menu

Privacy Policy
Terms & Conditions of Use
Forward-Looking Statements
Community Guidelines
References

© 2022 Copyright Chimerix. All rights reserved.